WealthCollab LLC Lowers Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

WealthCollab LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 41.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 89 shares of the healthcare conglomerate’s stock after selling 63 shares during the period. WealthCollab LLC’s holdings in UnitedHealth Group were worth $45,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Norges Bank acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $6,375,744,000. Raymond James Financial Inc. purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $1,914,740,000. Amundi lifted its position in shares of UnitedHealth Group by 97.2% during the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock valued at $3,183,132,000 after buying an additional 2,991,470 shares in the last quarter. Proficio Capital Partners LLC increased its holdings in UnitedHealth Group by 76,830.4% in the 4th quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock worth $955,388,000 after acquiring an additional 1,886,186 shares in the last quarter. Finally, Northern Trust Corp lifted its holdings in UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock valued at $4,807,527,000 after purchasing an additional 1,058,488 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 2.6 %

Shares of NYSE:UNH opened at $409.23 on Wednesday. The firm’s 50-day moving average is $499.59 and its two-hundred day moving average is $532.08. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $409.10 and a 1 year high of $630.73. The firm has a market capitalization of $372.49 billion, a PE ratio of 26.40, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the prior year, the business earned $6.91 EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.05%. UnitedHealth Group’s payout ratio is 35.18%.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on UNH. Oppenheimer decreased their price target on shares of UnitedHealth Group from $640.00 to $600.00 and set an “outperform” rating on the stock in a research note on Monday, April 21st. Erste Group Bank upgraded UnitedHealth Group to a “strong-buy” rating in a research report on Wednesday, April 16th. Robert W. Baird lowered their target price on shares of UnitedHealth Group from $640.00 to $510.00 and set an “outperform” rating on the stock in a research note on Tuesday. JPMorgan Chase & Co. decreased their price target on shares of UnitedHealth Group from $652.00 to $525.00 and set an “overweight” rating on the stock in a research note on Thursday, April 24th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Three equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $596.86.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.